Some of these indications include Glut1 deficiency, pyruvate dehydrogenase deficiency, infantile epileptic spasms syndrome, epilepsy with myoclonic‐atonic seizures, and formula‐fed children. This evidence concerns the gene SLC2A1 and hyperinsulinemic hypoglycemia, familial, 4.